Characterization of a Nonsense Mutation in the Ceruloplasmin Gene Resulting in Diabetes and Neurodegenerative Disease
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
We report here on the characterization of a mutation in the ceruloplasmin gene in a 45 year old woman with insulin-dependent diabetes mellitus who presented with the recent onset of gait disturbance and dysarthria. Physical examination revealed an ataxic gait, scanning speech and retinal degeneration. Magnetic resonance imaging of the brain was consistent with increased basal ganglia iron content and laboratory studies revealed a low serum iron concentration and no detectable serum ceruloplasmin. Nucleotide sequence analysis of the ceruloplasmin gene from this patient revealed a G to A substitution in exon 15 resulting in a nonsense mutation at amino acid 858 (Trp858ter). The patient's younger, neurologically asymptomatic brother was also found to be homozygous for this mutation. Taken together the clinical and genetic data support the concept of an essential and unique role for ceruloplasmin in human iron metabolism. Identification of this kindred extends the spectrum of ceruloplasmin gene mutations resulting in this autosomal recessive, late-onset neurodegenerative disease and highlights the importance of recognizing aceruloplasminemia as a genetic cause of diabetes and neurologic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.
Harris, Z. L., Takahashi, Y., Miyajima, H., Serizawa, M., MacGillivray, R. T., & Gitlin, J. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2539 · Cited by 558 · cited 5×
“Isolated leukocytes were lysed in hypotonic saline following buffy coat separation and DNA was then precipitated in ethanol and purified as described ( 8 ).”
InfluentialA mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans
Yoshida, K., Furihata, K., Takeda, S., Nakamura, A., Yamamoto, K., Morita, H., Hiyamuta, S., Ikeda, S.-I., Shimizu, N., & Yanagisawa, N. (1995) · Nature Genetics · doi:10.1038/ng0395-267 · Cited by 463 · cited 1×
“Most recently, molecular genetic analysis of two separate patients with lateonset neurodegenerative disease identified distinct mutations in the ceruloplasmin gene accounting for the clinical symptoms in these individuals (8, 9 ).”
The role of ceruloplasmin in iron metabolism.
Roeser, H. P., Lee, G. R., Nacht, S., & Cartwright, G. E. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106460 · Cited by 365 · cited 1×
“As noted previously, symptoms of aceruloplasminemia are not found in patients with Wilson disease because extrahepatic production of holoceruloplasmin is sufficient to provide the 5% of normal serum concentration necessary to sustain normal plasma iron turnover rates (8, 16 ).”
Hereditary hemochromatosis: A prevalent disorder of iron metabolism with an elusive etiology
Conrad, M. E., Umbreit, J. N., Moore, E. G., & Parmley, R. T. (1994) · American Journal of Hematology · doi:10.1002/ajh.2830470313 · Cited by 18
Cited by
C ERULOPLASMIN M ETABOLISM AND F UNCTION
Hellman, N. E., & Gitlin, J. D. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.012502.114457 · Cited by 933
Self-citationThe Role of Copper in Neurodegenerative Disease
Waggoner, D. J., Bartnikas, T. B., & Gitlin, J. D. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0250 · Cited by 863
Self-citationBioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Curtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537
“An exception is the rare, recessive, adult-onset disorder aceruloplasminemia (OMIM: 604290), which features iron accumulation associated with degeneration of the basal ganglia and retina as well as diabete”
BackgroundMetabolism and functions of copper in brain
Scheiber, I. F., Mercer, J. F. B., & Dringen, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.01.002 · Cited by 506
Iron misregulation in the brain: a primary cause of neurodegenerative disorders
Ke, Y., & Qian, Z. M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00353-3 · Cited by 340
Patel, B. N., & David, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20185 · Cited by 327
The many “faces” of copper in medicine and treatment
Hordyjewska, A., Popiołek, Ł., & Kocot, J. (2014) · BioMetals · doi:10.1007/s10534-014-9736-5 · Cited by 298
Genetic and molecular basis for copper toxicity
Harris, Z., & Gitlin, J. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.5.836 · Cited by 285
Self-citationAceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis
Harris, Z., Klomp, L., & Gitlin, J. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.5.972s · Cited by 256
Self-citationIron and neurodegenerative disorders
Thompson, K. J., Shoham, S., & Connor, J. R. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00510-x · Cited by 235
Use of desferrioxamine in the treatment of aceruloplasminemia
Miyajima, H., Takahashi, Y., Kamata, T., Shimizu, H., Sakai, N., & Gitlin, J. D. (1997) · Annals of Neurology · doi:10.1002/ana.410410318 · Cited by 173
Self-citationDoes cellular iron dysregulation play a causative role in Parkinson’s disease?
Kaur, D., & Andersen, J. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.01.003 · Cited by 123
Chen, H., Attieh, Z. K., Syed, B. A., Kuo, Y.-M., Stevens, V., Fuqua, B. K., Andersen, H. S., Naylor, C. E., Evans, R. W., Gambling, L., et al. (2010) · The Journal of Nutrition · doi:10.3945/jn.109.117531 · Cited by 122
Chang, B., Mandal, M. N. A., Chavali, V. R. M., Hawes, N. L., Khan, N. W., Hurd, R. E., Smith, R. S., Davisson, M. L., Kopplin, L., Klein, B. E. K., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn295 · Cited by 30
Metadata
- Authors
- Takahashi, Y., Miyajima, H., Shirabe, S., Nagataki, S., Suenaga, A., & Gitlin, J. D.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-01-01
- Volume
- 5
- Issue
- 1
- Pages
- 81-84
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2016497343
- Cited by
- 119
- References
- 4
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.